Professor Mats Wahlgren investigates the molecular pathogenesis of parasitic diseases. Previous positions include directorship of MTC (KI), the Multilateral Initiative on Malaria and the Infection and Vaccinology Programme (SSF). He has been trustee/ committee member of the HIV Research Trust, the Wellcome Trust and World Health Organisation. Professor Wahlgren has received a Fogarty Award, the Harford Visiting Professorship at Washington University, the Söderberg professorship of the Royal Swedish Academy of Sciences and a ’Distinguished Professor Award‘ from Karolinska Institutet. He is a member of the Nobel assembly. Professor Wahlgren is co-founder of Modus Therapeutics and several other biotech companies.